<DOC>
	<DOC>NCT00657891</DOC>
	<brief_summary>We are studying Xolair (omalizumab) to see it's effect on allergic blood cells. The blood tests will be done in a test tube to see if they react differently before and after treatment. The blood cells will be mixed with to whatever the person is allergic.</brief_summary>
	<brief_title>The Effect of Xolair (Omalizumab) on Allergy Blood Cells</brief_title>
	<detailed_description>Must be allergic-asthma with IgE between 30 and 700 IU/ml.</detailed_description>
	<mesh_term>Omalizumab</mesh_term>
	<criteria>2 year history of ragweed allergic rhinitis positive skin prick tests to ragweed &gt;5 mm wheal diameter serum IgE &lt;700 iU/m Use of prohibited medications (e.g. antihistamine in past 7 days and topical or oral corticosteroids in past 1 month, betaagonist or theophylline for 1 week History of immunotherapy in the past 2 years Exposure to Omalizumab in the past 2 years Clinically significant nonallergic or perennial rhinitis to avoid mediator release due to environmental allergens Asthma other than mild intermittent Women of childbearing potential who are not on an accepted form of birth control, as well as women who are breastfeeding Known sensitivity to study drug Xolair Patients with severe medical condition(s) that in the view of the investigator prohibits participation in the study Patients with a previous history of cancer Use of any other investigational agent in the last 30 days</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Allergic Asthma</keyword>
	<keyword>Anti IgE</keyword>
	<keyword>Xolair</keyword>
	<keyword>Basophil</keyword>
	<keyword>IL-13</keyword>
	<keyword>IL-4</keyword>
	<keyword>Histamine</keyword>
</DOC>